Cargando…

Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain

BACKGROUND: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candidate. The aim of this study was to analyze the PspA family and clade distribution among 112 Spanish pneumococci representatives of dominant clones among patients with invasive disease (n = 66) and nas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rolo, Dora, Ardanuy, Carmen, Fleites, Ana, Martín, Rogelio, Liñares, Josefina
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684541/ https://www.ncbi.nlm.nih.gov/pubmed/19419534 http://dx.doi.org/10.1186/1471-2180-9-80

Ejemplares similares

Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA)
Publicado: (1987)

Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
por: Rodrigues, Tasson C., et al.
Publicado: (2018)

Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice
por: Oliveira, Maria Leonor S., et al.
Publicado: (2010)

PspA Diversity, Serotype Distribution and Antimicrobial Resistance of Invasive Pneumococcal Isolates from Paediatric Patients in Shenzhen, China
por: Jiang, Hanfang, et al.
Publicado: (2021)

In vivo localizations of membrane stress controllers PspA and PspG in Escherichia coli
por: Engl, Christoph, et al.
Publicado: (2009)

Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization
por: Araujo, Adriano P., et al.
Publicado: (2021)

The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA
por: Genschmer, Kristopher R., et al.
Publicado: (2019)

Evaluation of polymer choice on immunogenicity of chitosan coated PLGA NPs with surface-adsorbed pneumococcal protein antigen PspA4Pro
por: Kaneko, Kan, et al.
Publicado: (2021)

Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence
por: Park, Sang-Sang, et al.
Publicado: (2021)

Membrane chaperoning by members of the PspA/IM30 protein family
por: Thurotte, Adrien, et al.
Publicado: (2017)

Towards Identifying Protective B-Cell Epitopes: The PspA Story
por: Khan, Naeem, et al.
Publicado: (2017)

Molecular Characterization of Pneumococcal Surface Protein A (PspA), Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Isolated from Pakistan
por: Khan, Faidad, et al.
Publicado: (2018)

Evidence for a second regulatory binding site on PspF that is occupied by the C-terminal domain of PspA
por: Heidrich, Eyleen Sabine, et al.
Publicado: (2018)

Invasive Pneumococcal Disease in Healthy Adults: Increase of Empyema Associated with the Clonal-Type Sweden(1)-ST306
por: Grau, Imma, et al.
Publicado: (2012)

Correction to: Molecular Characterization of Pneumococcal Surface Protein A (PspA), Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Isolated from Pakistan
por: Khan, Faidad, et al.
Publicado: (2018)

Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity
por: Wagner-Muñiz, Danielle A., et al.
Publicado: (2018)

Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae
por: Akbari, Elaheh, et al.
Publicado: (2019)

PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites
por: Lane, Jessica R., et al.
Publicado: (2023)

An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae
por: Mazumder, Lincon, et al.
Publicado: (2023)

The choline-binding proteins PspA, PspC, and LytA of Streptococcus pneumoniae and their interaction with human endothelial and red blood cells
por: Vilhena, Cláudia, et al.
Publicado: (2023)

A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide
por: Wang, Lichan, et al.
Publicado: (2019)

Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily
por: Liu, Jiwei, et al.
Publicado: (2021)

Fluoroquinolone Resistance in Penicillin-resistant Streptococcus pneumoniae Clones, Spain
por: de la Campa, Adela G., et al.
Publicado: (2004)

Evolution and genetic diversity of the Spain(23F)-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990–2012)
por: Domenech, A., et al.
Publicado: (2014)

Disease Isolates of Streptococcus pseudopneumoniae and Non-Typeable S. pneumoniae Presumptively Identified as Atypical S. pneumoniae in Spain
por: Rolo, Dora, et al.
Publicado: (2013)

Molecular mechanisms of the secretion of cytokines and chemokines from human monocytes activated by pneumococcal surface protein A (PspA): Roles of mitogen-activated protein kinases and NF-kappaB
por: Cao, Ju, et al.
Publicado: (2010)

Membrane Stored Curvature Elastic Stress Modulates Recruitment of Maintenance Proteins PspA and Vipp1
por: McDonald, Christopher, et al.
Publicado: (2015)

Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance
por: Thompson, Courtney D., et al.
Publicado: (2023)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
por: Càmara, Jordi, et al.
Publicado: (2017)

A Lower-Order Oligomer Form of Phage Shock Protein A (PspA) Stably Associates with the Hexameric AAA(+) Transcription Activator Protein PspF for Negative Regulation
por: Joly, Nicolas, et al.
Publicado: (2009)

Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007–2009): Implications for Future Vaccination Strategies
por: Ardanuy, Carmen, et al.
Publicado: (2012)

Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF)
por: Goulart, Cibelly, et al.
Publicado: (2019)

PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan
por: Hotomi, Muneki, et al.
Publicado: (2013)

Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
por: Yokota, Chieko, et al.
Publicado: (2023)

Spread of Streptococcus pneumoniae Serotype 8-ST63 Multidrug-Resistant Recombinant Clone, Spain
por: Ardanuy, Carmen, et al.
Publicado: (2014)

A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
por: Shafaghi, Mona, et al.
Publicado: (2023)

Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner
por: Vashishta, Mohit, et al.
Publicado: (2015)

Some Pneumococcal Serotypes Are More Frequently Associated with Relapses of Acute Exacerbations in COPD Patients
por: Domenech, Arnau, et al.
Publicado: (2013)

Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain
por: Mick, Virginie, et al.
Publicado: (2010)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11t2p3ide5r69sgctv7665hdot